Info
Stages I–II Hodgkin lymphoma
- PET adapted ABVD
- doxorubicin,
- bleomycin,
- vinblastine,
- dacarbazine ± RT
Favorable:
ABVD × 2–4 cycles ± RT (if PET ⊖ after 2 cycles reduce chemo or RT)
Unfavorable:
-
50 y, bulky mediastinum,
- “B” sx,
- ESR >50,
-
3 nodal sites
ABVD × 4–6 + RT (stop at 4 cycles if PET ⊖ after 2 cycles)